NU SKIN ENTERPRISES, INC. (NUS) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
34/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseNUS / S&P -26.74% / 15.20% |
LoseNUS / S&P -15.44% / 15.00% |
LoseNUS / S&P -322.28% / 50.40% |
| 2026-Q10/3 |
LoseNUS / S&P -23.79% / -4.33% |
LoseNUS / S&P -14.17% / 11.30% |
LoseNUS / S&P -236.71% / 27.70% |
| 2025-Q40/3 |
LoseNUS / S&P -20.63% / 2.65% |
LoseNUS / S&P -14.26% / 9.00% |
LoseNUS / S&P -208.16% / 13.40% |
| 2025-Q31/3 |
WinNUS / S&P 53.34% / 8.12% |
LoseNUS / S&P -12.10% / 4.61% |
LoseNUS / S&P -205.29% / 13.45% |
| 2025-Q20/3 |
LoseNUS / S&P 10.85% / 10.94% |
LoseNUS / S&P -11.79% / 4.83% |
LoseNUS / S&P -167.56% / 10.63% |
| 2025-Q12/3 |
WinNUS / S&P 6.21% / -4.27% |
LoseNUS / S&P -11.85% / 4.98% |
WinNUS / S&P 1028.57% / 10.57% |
| 2024-Q40/3 |
LoseNUS / S&P -5.78% / 2.41% |
LoseNUS / S&P -12.04% / 5.25% |
LoseNUS / S&P -1829.41% / 6.15% |
| 2024-Q30/3 |
LoseNUS / S&P -29.62% / 5.89% |
LoseNUS / S&P -11.37% / 5.89% |
LoseNUS / S&P -279.31% / 6.11% |
| 2024-Q20/3 |
LoseNUS / S&P -23.44% / 4.28% |
LoseNUS / S&P -9.70% / 5.38% |
LoseNUS / S&P -315.11% / 5.12% |
| 2024-Q10/3 |
LoseNUS / S&P -28.44% / 10.56% |
LoseNUS / S&P -9.38% / 5.71% |
LoseNUS / S&P -104.61% / 5.59% |
| 2023-Q40/3 |
LoseNUS / S&P -6.31% / 11.69% |
LoseNUS / S&P -11.53% / 6.81% |
LoseNUS / S&P -91.71% / 7.78% |
| 2023-Q31/3 |
LoseNUS / S&P -35.04% / -3.27% |
LoseNUS / S&P -15.73% / 7.52% |
WinNUS / S&P 54.67% / -5.03% |
| 2023-Q20/3 |
LoseNUS / S&P -14.59% / 8.74% |
LoseNUS / S&P -17.67% / 9.50% |
LoseNUS / S&P -37.67% / -8.57% |
| 2023-Q10/3 |
LoseNUS / S&P -5.87% / 7.50% |
LoseNUS / S&P -19.87% / 10.77% |
LoseNUS / S&P -43.91% / -15.69% |
| 2022-Q41/3 |
WinNUS / S&P 27.59% / 7.56% |
LoseNUS / S&P -17.44% / 11.88% |
LoseNUS / S&P -28.32% / -17.99% |
| 2022-Q30/3 |
LoseNUS / S&P -22.23% / -4.88% |
LoseNUS / S&P -14.21% / 13.47% |
LoseNUS / S&P -83.07% / -1.41% |
| 2022-Q21/3 |
WinNUS / S&P -8.79% / -16.10% |
LoseNUS / S&P -12.44% / 13.71% |
LoseNUS / S&P -50.88% / 11.04% |
| 2022-Q10/3 |
LoseNUS / S&P -4.89% / -4.60% |
LoseNUS / S&P -4.28% / 15.97% |
LoseNUS / S&P -35.48% / 42.23% |
| 2021-Q41/3 |
WinNUS / S&P 26.43% / 11.03% |
LoseNUS / S&P 4.41% / 15.00% |
LoseNUS / S&P -21.64% / 96.40% |
| 2021-Q31/3 |
LoseNUS / S&P -28.03% / 0.58% |
WinNUS / S&P 14.62% / 10.77% |
LoseNUS / S&P 49.66% / 69.42% |
| 2021-Q22/3 |
LoseNUS / S&P 7.79% / 8.55% |
WinNUS / S&P 22.96% / 6.58% |
WinNUS / S&P 70.04% / 51.81% |
| 2021-Q12/3 |
LoseNUS / S&P -2.45% / 6.17% |
WinNUS / S&P 18.41% / -1.06% |
WinNUS / S&P 56.13% / 7.39% |
| 2020-Q42/3 |
LoseNUS / S&P 9.83% / 12.15% |
WinNUS / S&P 6.67% / -3.72% |
WinNUS / S&P 17.74% / -33.42% |
| 2020-Q32/3 |
WinNUS / S&P 32.05% / 8.93% |
LoseNUS / S&P -4.10% / -2.04% |
WinNUS / S&P 42.31% / -27.10% |
| 2020-Q22/3 |
WinNUS / S&P 76.69% / 20.54% |
LoseNUS / S&P -11.59% / -0.46% |
WinNUS / S&P 19.73% / -27.11% |
| 2020-Q11/3 |
LoseNUS / S&P -45.89% / -19.60% |
LoseNUS / S&P -13.83% / 3.47% |
WinNUS / S&P 16.96% / -14.75% |
| 2019-Q41/3 |
LoseNUS / S&P -2.72% / 9.07% |
LoseNUS / S&P -9.65% / 5.36% |
WinNUS / S&P 42.86% / 2.99% |
| 2019-Q30/3 |
LoseNUS / S&P -12.97% / 1.70% |
LoseNUS / S&P -5.32% / 5.02% |
LoseNUS / S&P -25.71% / 0.21% |
| 2019-Q20/3 |
LoseNUS / S&P 3.85% / 4.30% |
LoseNUS / S&P 2.17% / 6.64% |
LoseNUS / S&P -14.89% / 8.65% |
| 2019-Q11/3 |
LoseNUS / S&P -21.50% / 13.65% |
WinNUS / S&P 12.11% / 8.12% |
LoseNUS / S&P -7.63% / 14.29% |
| 2018-Q41/3 |
LoseNUS / S&P -25.17% / -13.52% |
WinNUS / S&P 17.55% / 9.05% |
LoseNUS / S&P -8.05% / 18.23% |
| 2018-Q31/3 |
LoseNUS / S&P 5.89% / 7.71% |
WinNUS / S&P 24.14% / 10.21% |
LoseNUS / S&P 2.19% / 19.06% |
| 2018-Q22/3 |
WinNUS / S&P 6.55% / 3.43% |
WinNUS / S&P 16.74% / 9.03% |
LoseNUS / S&P -11.49% / 14.46% |
| 2018-Q11/3 |
WinNUS / S&P 8.59% / -0.76% |
LoseNUS / S&P 7.21% / 7.68% |
LoseNUS / S&P -16.44% / 12.46% |
| 2017-Q41/3 |
WinNUS / S&P 11.62% / 6.64% |
LoseNUS / S&P 3.23% / 7.03% |
LoseNUS / S&P -6.72% / 13.82% |
| 2017-Q30/3 |
LoseNUS / S&P -1.57% / 4.48% |
LoseNUS / S&P -4.64% / 5.68% |
LoseNUS / S&P 11.84% / 17.57% |
| 2017-Q22/3 |
WinNUS / S&P 13.89% / 3.09% |
LoseNUS / S&P -1.40% / 4.83% |
WinNUS / S&P 69.14% / 17.74% |
| 2017-Q12/3 |
WinNUS / S&P 17.12% / 6.07% |
LoseNUS / S&P 2.74% / 3.67% |
WinNUS / S&P 74.27% / 13.32% |
| 2016-Q41/3 |
LoseNUS / S&P -25.75% / 3.82% |
LoseNUS / S&P NUS unavailable / 2.09% |
WinNUS / S&P 12.44% / 7.05% |
| 2016-Q32/3 |
WinNUS / S&P 41.09% / 3.85% |
LoseNUS / S&P NUS unavailable / 0.20% |
WinNUS / S&P 2.08% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NUS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -59.73% | 20.78% |
| Annualized return | -59.73% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | NUS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -88.87% | 83.14% |
| Annualized return | -35.54% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | NUS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -88.75% | 319.30% |
| Annualized return | -19.62% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |